Shah, N. D., & Limetkai, B. N. (2017). The use of Medium-Chain Triglycerides in Gastrointestinal Disorders. Practical Gastroenterology, 20-28.
Smeets, R. L., Rao, R. V., Emst-de Vries van, S. E., De Pont, J. J., Miller, L. J., & Willems, P. H. (1998). Reduced cholecystokinin receptor phosphorylation and restored signalling in protein kinase C down-regulated rat pancreatic acinar cells. Pflugers Arch., 422-428.
Limetkai, B. N., & Zucker, S. D. (2008). Hyperammonemic encephalopathy caused by carnitine deficiency. J. Gen. Inter. Med., 210-213.
Symersky, T., Vu, M. K., & Frolich, M. (2002). The effect of equicaloric medium-chain and long-chain triglycerides on pancreas enzyme secretion. Clin. Physiol. Funct. Imaging, 307-311.
Sankararaman, S., & Sferra, T. (2018). Are We Going Nuts on Coconut Oil? Current Nutrition Reports, 107-115.
Ingle, D. L., Driedger, A., Traul, K. A., & Nakhasi, D. K. (1999). Dietary energy value of medium-chain triglycerides. Journal of Food Science, 960-963.
Shea, J. C., Bishop, M. D., & Parker, E. M. (2003). An enteral therapy containing medium-chain triglycerides and hydrolyzed peptides reduces postprandial pain associated with chronic pancreatitis. Pancreatology, 36-40.
Jeppesen, P. B., & Mortensen, P. B. (1998). The influence of a preserved colon on the absortion of medium chain fat in patients with small bowel resection. Gut, 478-483.
Abu Hilal, M., Layfield, D. M., & Di Fabio, F. (2013). Postoperative chyle leak after major pancreatic resections in patients who receive enteral feed; risk factors and management options. World J. Surg., 2918-2926.
McCray, S., & Parrish, C. R. (2011). Nutritional management of Chyle leaks. Practical gastroenterology, 12-32.
Smoke, A., & DeLegge, M. H. (2008). Chyle Leaks: Consensus on management? Nutr. Clin. Prac., 529-532.
Das, A., & Shah, P. S. (2010). Octreotide for the treatment of chylothorax in neonates. Cochrane database Syst. Rev., CD006388.
Jensen, G. L., Mascioli, E. A., & Meyer, L. P. (1989). Dietary modification of chyle composition in chylothorax. Gastroenterology.
Sahoo, T., Mangla, M. K., Sethi, A., & Thukral, A. (2018). Successful treatment of congenital chylothorax with skimmed milk and long course octreotide. BMJ Case Rep., 226347.
Neumann, L., Springer, T., Nieschke, K., Kostelka, M., & Dahnert, I. (2020). ChyloBEST: Chylothorax in infants and nutrition with low-fat breats milk. Pediatr. Cardiol., 108-113.
Hermon, M., Tenner, E., Gudrun, B., Strohmaier, W., Schlager, G., & Golej, J. (2019). Chylothorax and Chylous-like diseases in children: clinical management. Front Pediatr., 258.
Lieber, C. S., Lefevre, A., & Spritz, N. (1967). Difference in hepatic metabolism of long- and medium-chain fatty acids; the role of fatty acid chain length in the production of the alcohol fatty liver. The journal of clinical investigation, 451-460.
Nanji, A. A., Yang, E. K., & Fogt, F. (1996). Medium chain triglycerides and vitamin E reduce the severity of established experimental alcoholic liver disease. J Pharmacol. Exp. Ther., 1694-1700.
Ronis, M. J., Baumgardner, J. N., Sharma, N., Vantrease, J., Ferguson, M., Tong, Y., . . . Badger, T. M. (2013). Medium chain triglycerides dose-dependently prevent liver pathology in a rat model of non-alcoholic fatty liver disease. Exp. Biol. Med., 151-162.
Morgan, M. H., Bolton, C. H., Morris, J. S., & Read, A. E. (1974). Medium chain triglycerides and hepatic encephalopathy. Gut, 180-184.
Chamma, C. M., Bargut, T. C., Mandarim-de-Lacerda, C. A., & Aguila, M. B. (2017). A rich medium-chain triacylglycerol diet benefits adiposity but has adverse effects on the markers of hepatic lipogenesis and beta-oxidation. Food Funct., 778-787.
Williams, T. J., & Cervenka, M. C. (2017). The role for ketogenic diets in epilepsy and status epilepticus in adults. Clin. Neurophysiol. Pract., 154-160.
van Berkel, A. A., IJff, D. M., & Verkuyl, J. M. (2018). Cognitive benefits of the ketogenic diet in patients with epilepsy, a systematic overview. Epilepsy Behav., 69-77.
Sadeghifar, F., & Baute Penry, V. (2019). Mechanisms of uses of dietary therapy as a treatment for epilepsy: a review. Global advances in health and medicine, 1-4.
Liu, Y. C., & Wang, H. S. (2013). Medium-chain triglyceride ketogenic diet, an effective treatment for drug-resistant epilepsy and a comparison with other ketogenic diets. Biomed. J. , 9-15.
Augustin, K., Khabbush, A., Williams, S., Eaton, S., Orford, M., Cross, H., . . . Williams, R. S. (2018). Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders. Lancet Neurol., 84-93.
Cameros-Luna, L., & Massieu, L. (2020). Therapeutic strategies for ketosis induction and their potential efficacy for the treatment of acute brain injury and neurodegenerative diseases. Neurochem. Int., 104614.
Lilamand, M., Porte, B., Cognat, E., Hugon, J., Mouton-liger, F., & Paquet, C. (2020). Are ketogenic diets promising for Alzheimer's disease? a translational review. Alzheimer's Research & Therapy, 10.1186/s13195.
Abuduxikuer, K., Chen, R., Wang, Z. L., & Wang, J. S. (2019). Risk factors associated with mortality in neonatal intrahepatic cholestasis caused by citrin defiency (NICCD) and clinical implications. BMC Pediatr., 10.1186/s12887-018-1383-5.
Francavilla, R., Miniello, V. L., Brunetti, L., Lionette, M. E., & Armenio, L. (2003). Hepatitis and cholestasis in infancy: clinical and nutritional aspects. Acta Paediatr. Suppl., 10.1111/j.1651-2227.2003.tb00656.x.
Hayasaka, K., & Numakura, C. (2018). Adult-onset type II citrullinemia; Current insights and therapy. Appl. Clin. Genet., 163-170.
Biewer, E. S., Zurn, C., Arnold, R., Glockler, M., Schulte-Monting, J., Schlensak, C., & Dittrich, S. (2010). Chylothorax after surgery on congenital heart disease in newborns and infants - risk factors and efficacy of MCT diet. J. Cardiothorac. Surg., 10.1186/1749-8090-5-127.
Korff, S. G., Ross, J., Morella, K., & Taylor, S. N. (2019). Investigation of a common clinical approach to poor growth in preterm infants. Am. J. Perinatol., 10.1055/s-0039-1694724.
Arsenault, A. B., Gunsalus, K. T., Laforce-Nesbitt, S. S., Przytac, L., DeAngelis, E. J., Hurley, M. E., . . . Bliss, J. M. (2019). Dietary supplementation with medium-chain triglycerides reduces candida gastrointestinal colonization in preterm infants. Pediatr. Infect. Dis. J., 164-168.
Shah, N. D., & Limetkai, B. N. (2017). The use of Medium-Chain Triglycerides in Gastrointestinal Disorders. Practical Gastroenterology, 20-28.
Smeets, R. L., Rao, R. V., Emst-de Vries van, S. E., De Pont, J. J., Miller, L. J., & Willems, P. H. (1998). Reduced cholecystokinin receptor phosphorylation and restored signalling in protein kinase C down-regulated rat pancreatic acinar cells. Pflugers Arch., 422-428.
Limetkai, B. N., & Zucker, S. D. (2008). Hyperammonemic encephalopathy caused by carnitine deficiency. J. Gen. Inter. Med., 210-213.
Symersky, T., Vu, M. K., & Frolich, M. (2002). The effect of equicaloric medium-chain and long-chain triglycerides on pancreas enzyme secretion. Clin. Physiol. Funct. Imaging, 307-311.
Sankararaman, S., & Sferra, T. (2018). Are We Going Nuts on Coconut Oil? Current Nutrition Reports, 107-115.
Ingle, D. L., Driedger, A., Traul, K. A., & Nakhasi, D. K. (1999). Dietary energy value of medium-chain triglycerides. Journal of Food Science, 960-963.
Shea, J. C., Bishop, M. D., & Parker, E. M. (2003). An enteral therapy containing medium-chain triglycerides and hydrolyzed peptides reduces postprandial pain associated with chronic pancreatitis. Pancreatology, 36-40.
Jeppesen, P. B., & Mortensen, P. B. (1998). The influence of a preserved colon on the absortion of medium chain fat in patients with small bowel resection. Gut, 478-483.
Abu Hilal, M., Layfield, D. M., & Di Fabio, F. (2013). Postoperative chyle leak after major pancreatic resections in patients who receive enteral feed; risk factors and management options. World J. Surg., 2918-2926.
McCray, S., & Parrish, C. R. (2011). Nutritional management of Chyle leaks. Practical gastroenterology, 12-32.
Smoke, A., & DeLegge, M. H. (2008). Chyle Leaks: Consensus on management? Nutr. Clin. Prac., 529-532.
Das, A., & Shah, P. S. (2010). Octreotide for the treatment of chylothorax in neonates. Cochrane database Syst. Rev., CD006388.
Jensen, G. L., Mascioli, E. A., & Meyer, L. P. (1989). Dietary modification of chyle composition in chylothorax. Gastroenterology.
Sahoo, T., Mangla, M. K., Sethi, A., & Thukral, A. (2018). Successful treatment of congenital chylothorax with skimmed milk and long course octreotide. BMJ Case Rep., 226347.
Neumann, L., Springer, T., Nieschke, K., Kostelka, M., & Dahnert, I. (2020). ChyloBEST: Chylothorax in infants and nutrition with low-fat breats milk. Pediatr. Cardiol., 108-113.
Hermon, M., Tenner, E., Gudrun, B., Strohmaier, W., Schlager, G., & Golej, J. (2019). Chylothorax and Chylous-like diseases in children: clinical management. Front Pediatr., 258.
Lieber, C. S., Lefevre, A., & Spritz, N. (1967). Difference in hepatic metabolism of long- and medium-chain fatty acids; the role of fatty acid chain length in the production of the alcohol fatty liver. The journal of clinical investigation, 451-460.
Nanji, A. A., Yang, E. K., & Fogt, F. (1996). Medium chain triglycerides and vitamin E reduce the severity of established experimental alcoholic liver disease. J Pharmacol. Exp. Ther., 1694-1700.
Ronis, M. J., Baumgardner, J. N., Sharma, N., Vantrease, J., Ferguson, M., Tong, Y., . . . Badger, T. M. (2013). Medium chain triglycerides dose-dependently prevent liver pathology in a rat model of non-alcoholic fatty liver disease. Exp. Biol. Med., 151-162.
Morgan, M. H., Bolton, C. H., Morris, J. S., & Read, A. E. (1974). Medium chain triglycerides and hepatic encephalopathy. Gut, 180-184.
Chamma, C. M., Bargut, T. C., Mandarim-de-Lacerda, C. A., & Aguila, M. B. (2017). A rich medium-chain triacylglycerol diet benefits adiposity but has adverse effects on the markers of hepatic lipogenesis and beta-oxidation. Food Funct., 778-787.
Williams, T. J., & Cervenka, M. C. (2017). The role for ketogenic diets in epilepsy and status epilepticus in adults. Clin. Neurophysiol. Pract., 154-160.
van Berkel, A. A., IJff, D. M., & Verkuyl, J. M. (2018). Cognitive benefits of the ketogenic diet in patients with epilepsy, a systematic overview. Epilepsy Behav., 69-77.
Sadeghifar, F., & Baute Penry, V. (2019). Mechanisms of uses of dietary therapy as a treatment for epilepsy: a review. Global advances in health and medicine, 1-4.
Liu, Y. C., & Wang, H. S. (2013). Medium-chain triglyceride ketogenic diet, an effective treatment for drug-resistant epilepsy and a comparison with other ketogenic diets. Biomed. J. , 9-15.
Augustin, K., Khabbush, A., Williams, S., Eaton, S., Orford, M., Cross, H., . . . Williams, R. S. (2018). Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders. Lancet Neurol., 84-93.
Cameros-Luna, L., & Massieu, L. (2020). Therapeutic strategies for ketosis induction and their potential efficacy for the treatment of acute brain injury and neurodegenerative diseases. Neurochem. Int., 104614.
Lilamand, M., Porte, B., Cognat, E., Hugon, J., Mouton-liger, F., & Paquet, C. (2020). Are ketogenic diets promising for Alzheimer's disease? a translational review. Alzheimer's Research & Therapy, 10.1186/s13195.
Abuduxikuer, K., Chen, R., Wang, Z. L., & Wang, J. S. (2019). Risk factors associated with mortality in neonatal intrahepatic cholestasis caused by citrin defiency (NICCD) and clinical implications. BMC Pediatr., 10.1186/s12887-018-1383-5.
Francavilla, R., Miniello, V. L., Brunetti, L., Lionette, M. E., & Armenio, L. (2003). Hepatitis and cholestasis in infancy: clinical and nutritional aspects. Acta Paediatr. Suppl., 10.1111/j.1651-2227.2003.tb00656.x.
Hayasaka, K., & Numakura, C. (2018). Adult-onset type II citrullinemia; Current insights and therapy. Appl. Clin. Genet., 163-170.
Biewer, E. S., Zurn, C., Arnold, R., Glockler, M., Schulte-Monting, J., Schlensak, C., & Dittrich, S. (2010). Chylothorax after surgery on congenital heart disease in newborns and infants - risk factors and efficacy of MCT diet. J. Cardiothorac. Surg., 10.1186/1749-8090-5-127.
Korff, S. G., Ross, J., Morella, K., & Taylor, S. N. (2019). Investigation of a common clinical approach to poor growth in preterm infants. Am. J. Perinatol., 10.1055/s-0039-1694724.
Arsenault, A. B., Gunsalus, K. T., Laforce-Nesbitt, S. S., Przytac, L., DeAngelis, E. J., Hurley, M. E., . . . Bliss, J. M. (2019). Dietary supplementation with medium-chain triglycerides reduces candida gastrointestinal colonization in preterm infants. Pediatr. Infect. Dis. J., 164-168.
Bang, U. C., Semb, S., Nordgaard-Lassen, I., & Jensen, J. E. (2009). A descriptive cross-sectional study of the prevalence of 25-hydroxyvitamin D deficiency and association with bone markers in a hospitalized population. Nutr. Res., 671-675.
Tessier, A., & Chevalier, S. (2018). An update on protein, leucine, omega-3 fatty acids, and vitamin D in the prevention and treatment of sarcopenia and functional decline. Nutrients, 10.3390/nu10081099.
Grant, W. B., Lahore, H., McDonnell, S. L., Baggerly, C. A., French, C. B., Aliano, J. L., & Bhattoa, H. P. (2020). Evidence that vitamin D supplementation could reduce the risk of influenza and COVID-19 infections and deaths. Nutrients, 10.3390/nu12040988.
Cashman, K., Dowling, K., Skrabakova, Z., Gonzales-Gross, M., Valtuena, J., & Henauw de, S. (2016). Vitamin D deficiency in Europe: pandemic? Am. J. Clin. Nutr., 1033-1044.
Martucci, G., Tuzzolino, F., Arcadipane, A., Pieber, T., Schnedl, C., & Purkart, T. (2017). The effect of high-dose cholecalciferol on bioavailable vitamin D levels in critically ill patients: a post hoc analysis of the VITdAL-ICU trial. Intensiv. Care Med., 1732-1734.
Haq, A., Svobodova, J., Imran, S., Stanford, C., & Razzaque, M. (2016). Vitamin D deficiency: a single centre analysis of patients from 136 countries. J. Steroid Biochem. Mol. Biol., 209-213.
Lu, Z., Chen, T., Zhang, A., Persons, K., Kohn, N., Berkowitz, R., . . . Holick, M. (2007). An evaluation of the vitamin D3 content in fish: Is the vitamin D content adequate to satisfy the dietary requirement for vitamin D? J. Steroid Biochem. Mol. Biol., 642-644.
GOV.UK. (2020, November 28). Retrieved from Preparing for winter: vitamin D: https://www.gov.uk/government/publications/vitamin-d-supplementation-during-winter-phe-and-nice statement/statement-from-phe-and-nice-on-vitamin-d-supplementation-during-winter
National Institutes of Health. (2021, January 29). Retrieved from Vitamin D: https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/
Amrein, K., Scherkl, M., Hoffmann, M., Neuwersch-Sommeregger, S., Kostenberger, M., Tmava Berisha, A., . . . Malle, O. (2020). Vitamin D deficiency 2.0: an update on the current status worldwide. Eur. J. Clin. Nutr., doi.org/10.1038/s41430-020-0558-y.
Holick, M., Binkley, N., Bischoff-Ferrari, H., Gordon, C., Hanley, D., & Heany, R. (2011). Evaulation, treatment and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab., 1911-1930.
Vieth, R. (2004). Vitamin D is not a hormone, and not a synonym for 1,25-dihydroxy-vitamin D, its analogs of deltanoids. J. Steroid Biochem. Mol. Biol., 89-90.
Vieth, R. (2020). Vitamin D supplementation: cholecalciferol, calcifediol, and calcitriol. . Eur. J. Clin. Nutr., doi.org/10.1038/s41430-020-0697-1.
Vieth, R. (2007). Vitamin D toxicity, policy, and science. J. Bone Miner. Res, V64-V68.
EFSA Panel on dietitic products, E. (2012). Scientific opinion on the tolerable upper intake levels of vitamin D. EFSA J., 2813.
Hathcock, J., Shao, A., Vieth, R., & Heaney, R. (2007). Risk assessment for vitamin D. Am. J. Clin. Nutr., 6-18.
Martineau, A., Jollife, D., Hooper, R., Greenberg, L., Aloia, J., & Bergman, P. (2017). Vitamin D supplementation to prevent acute respiratory tract infections; systematic review and meta-analysis of individual participant data. B. M. J., i6583.
Bjelakovic, G., Gluud, L., Nikolova, D., Whitfield, K., Wetterslev, J., & Simonetti, R. (2014). Vitamin D supplementation for prevention of mortality in adults. Cochrane Datab. Syst. Rev., doi.org/10.1002/14651858.CD007470.pub3.
Gaksch, M., Jorde, R., Grimnes, G., Joakimsen, R., Schirmer, H., & Wilsgaard, T. (217). Vitamin D and mortality: Individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a Eurpoean consortium. PLOS ONE, e0170791.
Vos, R., Ruttens, D., Verleden, S., Vandermeulen, E., Bellon, H., & Van Herck, A. (2017). High-dose vitamin D after lung transplantation: a randomized trial. J. Heart Lung Transplant, 897-905.
Ma, H., Zhou, T., Heianza, Y., & Qi, L. (2021). Habitual use fo vitamin D supplements and risk of coronavirus disease 2019 (COVID-19) infcetion: a prospective study in UK biobank. Am. J. Clin. Nutr., doi:101093/ajcn/nqaa381.
Demir, M., Demir, F., & Aygun, H. (2021). Vitamin D deficiency is associated with COVID-19 positivity and the severity of the diseases. J. Med. Virol., doi: 10.1002/jm.26832.
Rostami, M., Tehrani, F., Simbar, M., Bidhendi Yarandi, R., Minooe, S., & Hollis, B. (2018). Effectiveness of prenatal vitamin D deficiency screening and treatment program: a stratified randomized field trial. J. Clin. Endocrinol. Metab., 2936-2948.
Kusunose, K., Okushi, Y., Okayama, Y., Zheng, R., Abe, M., Nakai, M., . . . Tobiume, T. (2021). Association between vitamin D and heart failure mortality in 10,974 hospitalized individuals. Nutrients, doi:10.3390/nu13020335.
Deutz, N. E., Bauer, J. M., Barazzoni, R., Biolo, G., Boirie, Y., Bosy-Westphal, A., . . . Calder, P. C. (2014). Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN expert group. Clin. Nutr., 929-936.
Wagner, I., & Musso, H. (1983). New Naturally occurring amino acids. Angewandte Chemie International edition in English, 816-828.
Dancojocari. (n.d.). own work. wikimedia.
Young, V. R. (1994). Adult amino acid requirements: the case for a major revision in current recommendations. J. Nutr., 1517s-1523s.
Dietzen, D. J. (2018). Amino acids, peptides, and proteins Textbook of clinical chemistry and molecular diagnostics. Elsevier.
Carbone, J. W., & Pasiakos, S. M. (2019). Dietary protein and muscle mass: translating science to application. Nutrients, 1136.
Carbone, J. W., McClung, J. P., & Pasiakos, S. M. (2019). Recent advances in the characterization of skeletal muscle and whole-body protein responses to dietary protein and exercise during negative energy balance. Adv. Nutri., 70-79.
Loenneke, J. P., Loprinzi, P. D., Murphy, C. H., & Phillips, S. M. (2016). Per meal dose and frequency of protein consumption is associated with lean mass and muscle performance. Clin. Nutr., 1506-1511.
Berner, L. A., Becker, G., Wise, M., & Doi, J. (2013). Characterization of dietary protein among older adults in the United States: Amount, animal sources, and meal patterns. J. Acad. Nutr. Diet., 809-815.
Schaafsma, G. (2012). Advantages and limitations of the protein digestibility-corrected amino acid score (PDCAAS) as a method for evaluating protein quality in human diets. Br. J. Nutr., S333-S336.
Lonnie, M., Hooker, E., Brunstrom, J. M., Corfe, B. M., Green, M. A., Watson, A. W., . . . Johnstone, A. M. (2018). Protein for life: Review of optimal protein inake, sustainable dietary sources and the effect on appetite in ageing adults. Nutrients, 360.
Kiesswetter, E., Sieber, C. C., & Volkert, D. (2020). Protein intake in older people. Gerontologie+Geriatrie, 10.1007/s00391-020-01723-4.
MNI. (2018). Medical Nutrition Dossier. Retrieved from https://medicalnutritionindustry.com/medical-nutrition/medical-nutrition-dossier/
Tournadre, A., Vial, G., Capel, F., Soubrier, M., & Boirie, Y. (2019). Sarcopenia. Joint Bone Spine, 309-314.
Bonnefoy, B., Gilbert, T., Bruyere, O., Paillaud, E., Raynaud-Simon, A., Guerin, O., . . . Berrut, G. (2019). Protein supplementation to prevent loss in muscle mass and strength in frail older patients: a review. Geriatr. Psychol. Neuropsychiatr. Vieil., 137-143.
Wojzischke, J., Wijngaarden van, J., Berg van den, C., Cetinyurek-yavuz, A., Diekmann, R., Luiking, Y., & Bauer, J. (2020). Nutritional status and functionality in geriatric rehabilitation patients: a systematic review and meta-analysis. Eur. Geriatr. Med., 195-207.
Tieland, M., Borgonjen-van den Berg, K. J., Loon van, L. J., & Groot de, L. C. (2012). Dietary protein intake in community-dwelling, frail, and institutionalized elderly people: scope for improvement. Eur. J. Nutr., 173-179.
Bossola, M., Pacelli, F., Rosa, F., Tortorelli, A., & Bastista, D. G. (2011). Review: does nutrition support stimulate tumor growth in humans? Nutr. Clin. Pract., 174-180.
Prado, C. M., Purcell, S. A., & Laviano, A. (2020). Nutrition interventions to treat low muscle mass in cancer. Journal of cachexia, sarcopenia and muscle, 366-380.
Arends, J., Bertz, H., Bozzetti, F., Calder, P. C., Deutz, N. E., Erickson, N., . . . McMillan, D. C. (2017). ESPEN expert group recommendations for action against cancer-related malnutrition. Clinical Nutrition, 1187-1196.
Martin, L., Birdsell, L., MacDonald, N., Reiman, T., Clandinin, M. T., & McCargar, L. J. (2013). Cancer cachexia in the age of obesity; skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J. Clin. Oncol., 1539-1547.
Bauer, J., Morley, J. E., Schols, A. M., Ferrucci, L., Cruz-Jentoft, A. J., & Dent, E. (2019). Sarcopenia: a time for action. An SCWD Position Paper. J. Cachexia Sarcopenia Muscle, 0.
Bozzetti, F. (2013). Nutritional support of the oncology patient. Crit. Rev. Oncol. Hematol., 172-200.
Collins, P. F., Yang, I. A., Chang, Y., & Vaughan, A. (2019). Nutritional support in chronic obstructive pumonary disease (COPD): an evidence update. J. Thorac Dis., S2230-S2237.
Collins, P. F., Elia, M., & Stratton, R. J. (2013). Nutritional support and functional capacity in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respirology, 616-629.
Habaybeh, D., Bordinhon de Moraes, M., Slee, A., & Avgerinou, C. (2020). Nutritional interventions for heart failure patients who are malnourished or at risk of malnutrition or chachexia: a systematic review and meta-analysis. Haert Failure Reviews, 10.1007/s10741-020-09937-9.
Nichols, S., McGregor, G., Al-Mohammad, A., Ali, A. N., Tew, G., & O'Doherty, A. F. (2019). The effect of protein and essential amino acid supplementation on muscle strenght and performance in patients with chronic heart failure: a systematic review. Eur. J. of Nutr., 10.1007/s00394-019-02108-z.
Plauth, M., Bernal, W., Dasarathy, S., Merli, M., Plank, L. D., Schutz, T., & Bischoff, S. C. (2019). ESPEN guideline on clinical nutrition in liver disease. Clinical Nutrition, 485-521.
Singer, P., Reintam Blaser, A., Berger, M. M., Alhazzani, W., Calder, P. C., Casaer, M. P., . . . Montejo, J. C. (2019). ESPEN guideline on clinical nutrition in the intensive care unit. Clinical nutrition, 48-79.
Weijs, P. J., Stapel, S. N., Groot de, S. D., Driessen, R. H., Jong, E., & Girbes, A. R. (2012). Optimal protein and energy mortality in mechanically ventilated critically ill patients: a prospective cohort study. J. Parenter. Enteral Nutr., 60e8.
Bang, U. C., Semb, S., Nordgaard-Lassen, I., & Jensen, J. E. (2009). A descriptive cross-sectional study of the prevalence of 25-hydroxyvitamin D deficiency and association with bone markers in a hospitalized population. Nutr. Res., 671-675.
Deutz, N. E., Bauer, J. M., Barazzoni, R., Biolo, G., Boirie, Y., Bosy-Westphal, A., . . . Calder, P. C. (2014). Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN expert group. Clin. Nutr., 929-936.
Ljungqvist, O., & Man, F. d. (2009). Under Nutrition: A major health problem in Europe. Nutr. Hosp., 368-70.
Guest, J., Panca, M., Baeyens, J. P., Man, F. d., Ljungqvist, O., Pichard, C., . . . Wilson, L. (2011). Health economic impact of managing patients following a community-based diagnosis of malnutrition in the UK. Clin. Nutr., 422-429.
Kaiser, M. J., Bauer, J. M., Ramsch, C., Uter, W., Guigoz, Y., Cederholm, T., . . . Maggio, M. (2010). Frequency of malnutrition in older adults: a multinational perspective using the mini nutritional assessment. J. Am. Geriatr. Soc., 1734-1738.
Hulst, J. M., Zwart, H., Hop, W. C., & Joosten, K. F. (2010). Dutch national survey to test the strongkids nutritional risk screening tool in hospitalized children. Clin. Nutr., 106-111.
Khalatbari-Soltani, S., Mestral, C. d., & Marques-Vidal, P. (2019). Sixteen years trends in reported undernutrition. Clin. Nutr., 271-278.
MNI. (2018). Medical Nutrition Dossier. Retrieved from https://medicalnutritionindustry.com/medical-nutrition/medical-nutrition-dossier/
Correia, M. I., Perman, M. I., Pradelli, L., Omaralsaleh, A. J., & Waitzberg, D. L. (2018). Economic burden of hospital malnutrition and the cost-benefit of supplemental parenteral nutrition in critically ill patients in Latin America. Journal of Medical Economics, 1047-1056.
Finch, S., Doyle, W., Lowe, C., Bates, C. J., Prentice, A., & Smithers, G. (1998). National diet and nutrition survey: people aged 65 years and over. London: Stationary Office.
Schaafsma, G. (2012). Advantages and limitations of the protein digestibility-corrected amino acid score (PDCAAS) as a method for evaluating protein quality in human diets. Br. J. Nutr., S333-S336.
Lonnie, M., Hooker, E., Brunstrom, J. M., Corfe, B. M., Green, M. A., Watson, A. W., . . Johnstone, A. M. (2018). Protein for life: Review of optimal protein inake, sustainable dietary sources and the effect on appetite in ageing adults. Nutrients, 360.
Kiesswetter, E., Sieber, C. C., & Volkert, D. (2020). Protein intake in older people. Gerontologie+Geriatrie, 10.1007/s00391-020-01723-4.
Wagner, I., & Musso, H. (1983). New Naturally occurring amino acids. Angewandte Chemie International edition in English, 816-828.
Dancojocari. (n.d.). own work. wikimedia.
Young, V. R. (1994). Adult amino acid requirements: the case for a major revision in current recommendations. J. Nutr., 1517s-1523s.
Dietzen, D. J. (2018). Amino acids, peptides, and proteins Textbook of clinical chemistry and molecular diagnostics. Elsevier.
Carbone, J. W., & Pasiakos, S. M. (2019). Dietary protein and muscle mass: translating science to application. Nutrients, 1136.
Carbone, J. W., McClung, J. P., & Pasiakos, S. M. (2019). Recent advances in the characterization of skeletal muscle and whole-body protein responses to dietary protein and exercise during negative energy balance. Adv. Nutri., 70-79.
Calvero. (n.d.). Selfmade with Chemdraw, public domain.
Shah, N. D., & Limetkai, B. N. (2017). The use of Medium-Chain Triglycerides in Gastrointestinal Disorders. Practical Gastroenterology, 20-28.
Ingle, D. L., Driedger, A., Traul, K. A., & Nakhasi, D. K. (1999). Dietary energy value of medium-chain triglycerides. Journal of Food Science, 960-963.
Smeets, R. L., Rao, R. V., Emst-de Vries van, S. E., De Pont, J. J., Miller, L. J., & Willems, P. H. (1998). Reduced cholecystokinin receptor phosphorylation and restored signalling in protein kinase C down-regulated rat pancreatic acinar cells. Pflugers Arch., 422-428.
Limetkai, B. N., & Zucker, S. D. (2008). Hyperammonemic encephalopathy caused by carnitine deficiency. J. Gen. Inter. Med., 210-213.
Symersky, T., Vu, M. K., & Frolich, M. (2002). The effect of equicaloric medium-chain and long-chain triglycerides on pancreas enzyme secretion. Clin. Physiol. Funct. Imaging, 307-311.
Saunders, J., Smith, T., & Stroud, M. (2019). Malnutrition and undernutrition. Medicine, 152-158.
Selimoglu, M., Kansu, A., Aydogdu, S., Sarioglu, A., Erdogan, S., Dalgic, B., . . . Cokugras, F. (2021). Nutritional support in malnourished children with comprised gastrointestinal function: utility of peptide-based enteral therapy. Frontiers in Pediatrics, doi: 10.3389/fped.2021.610275.
Phillips, V., Short, N., Turner, C., & Rece, J. (2005). Peptide-based formulas: the neutraceuticals of enteral feeding. Retrieved from www.sci-health.org/sos/html_powerpoints/Phillips_ECPN_peptides.pdf
Ibrahim, H., Mansour, M., & Gendy el, Y. (2020). Peptide-based formula versus standard-based polymeric formula for critically ill children: is it superior for patients' tolerance? Arch. Med. Sci., 592-596.
Brinson, R., Hanumanthu, S., & Pitts, W. (1989). A reappraisal of the peptide-based enteral formulas: clinical applications. Nutr. Clin. Pract., 211-217.
Bang, U. C., Semb, S., Nordgaard-Lassen, I., & Jensen, J. E. (2009). A descriptive cross-sectional study of the prevalence of 25-hydroxyvitamin D deficiency and association with bone markers in a hospitalized population. Nutr. Res., 671-675.
Tessier, A., & Chevalier, S. (2018). An update on protein, leucine, omega-3 fatty acids, and vitamin D in the prevention and treatment of sarcopenia and functional decline. Nutrients, 10.3390/nu10081099.
Grant, W. B., Lahore, H., McDonnell, S. L., Baggerly, C. A., French, C. B., Aliano, J. L., & Bhattoa, H. P. (2020). Evidence that vitamin D supplementation could reduce the risk of influenza and COVID-19 infections and deaths. Nutrients, 10.3390/nu12040988.
Deutz, N. E., Bauer, J. M., Barazzoni, R., Biolo, G., Boirie, Y., Bosy-Westphal, A., . . . Calder, P. C. (2014). Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN expert group. Clin. Nutr., 929-936.
Ljungqvist, O., & Man, F. d. (2009). Under Nutrition: A major health problem in Europe. Nutr. Hosp., 368-70.
Guest, J., Panca, M., Baeyens, J. P., Man, F. d., Ljungqvist, O., Pichard, C., . . . Wilson, L. (2011). Health economic impact of managing patients following a community-based diagnosis of malnutrition in the UK. Clin. Nutr., 422-429.
Kaiser, M. J., Bauer, J. M., Ramsch, C., Uter, W., Guigoz, Y., Cederholm, T., . . . Maggio, M. (2010). Frequency of malnutrition in older adults: a multinational perspective using the mini nutritional assessment. J. Am. Geriatr. Soc., 1734-1738.
Hulst, J. M., Zwart, H., Hop, W. C., & Joosten, K. F. (2010). Dutch national survey to test the strongkids nutritional risk screening tool in hospitalized children. Clin. Nutr., 106-111.
Khalatbari-Soltani, S., Mestral, C. d., & Marques-Vidal, P. (2019). Sixteen years trends in reported undernutrition. Clin. Nutr., 271-278.
MNI. (2018). Medical Nutrition Dossier. Retrieved from https://medicalnutritionindustry.com/medical-nutrition/medical-nutrition-dossier/
Correia, M. I., Perman, M. I., Pradelli, L., Omaralsaleh, A. J., & Waitzberg, D. L. (2018). Economic burden of hospital malnutrition and the cost-benefit of supplemental parenteral nutrition in critically ill patients in Latin America. Journal of Medical Economics, 1047-1056.
Finch, S., Doyle, W., Lowe, C., Bates, C. J., Prentice, A., & Smithers, G. (1998). National diet and nutrition survey: people aged 65 years and over. London: Stationary Office.
Schaafsma, G. (2012). Advantages and limitations of the protein digestibility-corrected amino acid score (PDCAAS) as a method for evaluating protein quality in human diets. Br. J. Nutr., S333-S336.
Lonnie, M., Hooker, E., Brunstrom, J. M., Corfe, B. M., Green, M. A., Watson, A. W., . . . Johnstone, A. M. (2018). Protein for life: Review of optimal protein inake, sustainable dietary sources and the effect on appetite in ageing adults. Nutrients, 360.
Kiesswetter, E., Sieber, C. C., & Volkert, D. (2020). Protein intake in older people. Gerontologie+Geriatrie, 10.1007/s00391-020-01723-4.
Mikkelsen, K., & Apostolopoulos, V. (2018). B Vitamins and ageing. Subcell Biochem., 451-470.
Tournadre, A., Vial, G., Capel, F., Soubrier, M., & Boirie, Y. (2019). Sarcopenia. Joint Bone Spine, 309-314.
Bonnefoy, B., Gilbert, T., Bruyere, O., Paillaud, E., Raynaud-Simon, A., Guerin, O., . . . Berrut, G. (2019). Protein supplementation to prevent loss in muscle mass and strength in frail older patients: a review. Geriatr. Psychol. Neuropsychiatr. Vieil., 137-143.
Wojzischke, J., Wijngaarden van, J., Berg van den, C., Cetinyurek-yavuz, A., Diekmann, R., Luiking, Y., & Bauer, J. (2020). Nutritional status and functionality in geriatric rehabilitation patients: a systematic review and meta-analysis. Eur. Geriatr. Med., 195-207.
Tieland, M., Borgonjen-van den Berg, K. J., Loon van, L. J., & Groot de, L. C. (2012). Dietary protein intake in community-dwelling, frail, and institutionalized elderly people: scope for improvement. Eur. J. Nutr., 173-179.
Bossola, M., Pacelli, F., Rosa, F., Tortorelli, A., & Bastista, D. G. (2011). Review: does nutrition support stimulate tumor growth in humans? Nutr. Clin. Pract., 174-180.
Prado, C. M., Purcell, S. A., & Laviano, A. (2020). Nutrition interventions to treat low muscle mass in cancer. Journal of cachexia, sarcopenia and muscle, 366-380.
Arends, J., Bertz, H., Bozzetti, F., Calder, P. C., Deutz, N. E., Erickson, N., . . . McMillan, D. C. (2017). ESPEN expert group recommendations for action against cancer-related malnutrition. Clinical Nutrition, 1187-1196.
Martin, L., Birdsell, L., MacDonald, N., Reiman, T., Clandinin, M. T., & McCargar, L. J. (2013). Cancer cachexia in the age of obesity; skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J. Clin. Oncol., 1539-1547.
Bauer, J., Morley, J. E., Schols, A. M., Ferrucci, L., Cruz-Jentoft, A. J., & Dent, E. (2019). Sarcopenia: a time for action. An SCWD Position Paper. J. Cachexia Sarcopenia Muscle, 0.
Collins, P. F., Yang, I. A., Chang, Y., & Vaughan, A. (2019). Nutritional support in chronic obstructive pumonary disease (COPD): an evidence update. J. Thorac Dis., S2230-S2237.
Collins, P. F., Elia, M., & Stratton, R. J. (2013). Nutritional support and functional capacity in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respirology, 616-629.
Habaybeh, D., Bordinhon de Moraes, M., Slee, A., & Avgerinou, C. (2020). Nutritional interventions for heart failure patients who are malnourished or at risk of malnutrition or chachexia: a systematic review and meta-analysis. Haert Failure Reviews, 10.1007/s10741-020-09937-9.
Nichols, S., McGregor, G., Al-Mohammad, A., Ali, A. N., Tew, G., & O'Doherty, A. F. (2019). The effect of protein and essential amino acid supplementation on muscle strenght and performance in patients with chronic heart failure: a systematic review. Eur. J. of Nutr., 10.1007/s00394-019-02108-z.
Plauth, M., Bernal, W., Dasarathy, S., Merli, M., Plank, L. D., Schutz, T., & Bischoff, S. C. (2019). ESPEN guideline on clinical nutrition in liver disease. Clinical Nutrition, 485-521.
Weimann, A., Braga, M., Carli, F., Higashiguchi, T., Hubner, M., Klek, S., . . . Singer, P. (2017). ESPEN guideline: clinical nutrition in surgery. Clinical Nutrition, 623-650.
Williams, D. G., Molinger, J., & Wischmeyer, P. E. (2019). The malnourished surgery patient: a silent epidemic in perioperative outcomes? Curr. Opin. Anaesthesiol., 405-411.
Gillis, C., & Carli, F. (2015). Promoting perioperative metabolic and nutritional care. Anesthesiology, 1455-1472.
Singer, P., Reintam Blaser, A., Berger, M. M., Alhazzani, W., Calder, P. C., Casaer, M. P., . . . Montejo, J. C. (2019). ESPEN guideline on clinical nutrition in the intensive care unit. Clinical nutrition, 48-79.
Weijs, P. J., Stapel, S. N., Groot de, S. D., Driessen, R. H., Jong, E., & Girbes, A. R. (2012). Optimal protein and energy mortality in mechanically ventilated critically ill patients: a prospective cohort study. J. Parenter. Enteral Nutr., 60e8.
Bisschoff, S. C., Austin, P., Boeykens, K., Chourdakis, M., Cuerda, C., Jonkers-Schuitema, C., . . . Pironi, L. (2020). ESPEN guideline on home enteral nutrition. Clinical Nutrition, 5-22.
Smith, T., Cawood, A., Walters, E., Guildford, N., & Stratton, R. (2020). Ready-made oral nutritional supplements improve nutritional outcome and reduce health care use - a randomised trial in older malnourished people in primary care. Nutrients, doi:10.3390/nu12020517.
Hubbard, G., Elia, M., Holdoway, A., & Stratton, R. (2012). A systematic review of compliance to oral nutritional supplements. Clin. Nutrition, 293-312.
Serguy, D., Hubert, H., Robert, J., Meunier, J., Guerin, O., & Raynaud-Simon, A. (2020). Compliance to ral nutritional supplementation decreases the risk of hospitalisation in malnourished older adults without extra health care cost: Prospective observational cohort study. Clin. Nutrition, 1900-1907.